How do biotechs use Web of Science?

The world of biotech companies changes rapidly, alongside the constantly evolving research landscape. According to OECD, there are over 11,500 biotech firms in the US, with $38.5 billion in R&D expenditures. 1

And there are 2.5 million scientific articles published in a year.  How can biotechs keep up with the pace of innovation?  One way is to access the best research around the world using the Web of Science Core Collection.  We carefully select the best research literature- journals, conference, and  books- so you don’t have to. You can trust that you are using the most important research occurring around the globe, in all fields of science. 

On March 1, 2017, we conducted a webinar to show how Web of Science Core Collection can support the business strategy of bioetchs.  Our webinar focused on two topics: CRISPR/Cas9 and cannabidiol (CBD). 

Stay up to date with the latest preclinical research on CRISPR/Cas9

In the early days of CRISPR, Clarivate Analytics knew this gene editing technique was going to be big. Back in October 2014, we identified it as a hot, emerging topic using our Research Fronts methodology.  We use our vast citation network to identify clusters of papers that are frequently cited together (co-citation), suggesting the emergence of a new research field. The CRISPR breakthrough continues to make news in the science and business worlds.  While startups based on this technology are rapidly emerging, the debates over patent ownership of this valuable method continue3.

Web of Science Core Collection can tell us where CRISPR research is occurring. The US and China are taking the lead, as indicated by this trend graph of publication output.

graph liz deitz article

Explosion of CRISPR/Cas9 research around the globe -2013-2016

 

We can also see which institutions and authors are producing CRISPR research, and which articles are having the most impact.  For example, this July 2016 article from Nature Bioetchnology, DNA-guided genome editing using the Natronobacterium gregoryi Argonaute,  has received 27 citaitons to date, making it a Highly Cited paper as well as a Hot Paper, compared to others in its field.  It has also be used 342 times accoring to our Usage Count measure.  Our data will continue to track the exciting journey of CRISPR/Cas9 as it revolutionizes biomedicine.

 

Identify new customers for your products- Cannabidiol (CBC)

The second biotech use case we discussed in our webinar was identifying the publishing authors on a topic for outreach and marketing of a product.  The market for medical marijuana is rapidly growing as more and more US states, as well as other countries, legalize medical use of marijuana4.   As a result, research output on medical applications of cannabis has been growing.  In our webinar, we focused on understanding the research landscape of cannabidiol (CBD), a promising cannabinoid with many medicinal properties without psychoactivity.  We explored the centers of activity for CBD research, including Brazil, Israel, US, and UK.

chart liz deitz article

 

Top 10 institutions publishing on cannabidiol (CBD)-1980-2016

 

For companies producing medical grade CBD, we discussed our Web of Science mailing list service to market to researchers publishing on this topic across the many journals in the Web of Science Core Collection.  Through this service, you can target an email campaign to authors based on their field of research, funding source, journals of publication, citation count, and other attributes. 

If you missed the webinar, you can request the recording here >

Contact us for a full demonstration of Web of Science Core Collection and a complimentary trial.

 

1 http://www.oecd.org/sti/inno/keybiotechnologyindicators.htm     

2 http://www.stm-assoc.org/2015_02_20_STM_Report_2015.pdf

http://www.sciencemag.org/news/2017/02/round-one-crispr-patent-legal-battle-goes-broad-institute

4 http://www.cnbc.com/2016/10/21/the-next-big-billion-dollar-cannabis-markets-investors-are-rushing- to.html